Exact Sciences

$119.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$2.32 (+2.00%) Today
+$1.25 (+1.06%) As of 7:18 AM EST after-hours

Why Robinhood?

You can buy or sell Exact Sciences and other stocks, options, and ETFs commission-free!

About EXAS

Exact Sciences Corporation Common Stock, also called Exact Sciences, is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI. The listed name for EXAS is Exact Sciences Corporation Common Stock.

CEO
Kevin T. Conroy
Employees
4,110
Headquarters
Madison, Wisconsin
Founded
1995
Market Cap
18.80B
Price-Earnings Ratio
Dividend Yield
Average Volume
1.46M
High Today
$121.06
Low Today
$116.00
Open Price
$117.32
Volume
1.07M
52 Week High
$141.90
52 Week Low
$35.25

Collections

EXAS Earnings

-$0.66
-$0.44
-$0.22
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 9, Pre-Market

You May Also Like